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Screening versus routine practice in detection of atrial
fibrillation in patients aged 65 or over: cluster randomised
controlled trial
David A Fitzmaurice, professor of primary care,1 F D Richard Hobbs, professor, head of department,1
Sue Jowett, research fellow,1 JonathonMant, reader,1 Ellen TMurray, research fellow,1 RogerHolder, head of
statistics,1 J P Raftery, professor of health technology assessment,2 S Bryan, professor of health economics,3
Michael Davies, consultant cardiologist,4 Gregory Y H Lip, professor of cardiovascular medicine,5
T F Allan, senior lecturer6
ABSTRACT
Objectives To assess whether screening improves the
detection of atrial fibrillation (cluster randomisation) and
to compare systematic and opportunistic screening.
DesignMulticentred cluster randomised controlled trial,
with subsidiary trial embedded within the intervention
arm.
Setting 50 primary care centres in England, with further
individual randomisation of patients in the intervention
practices.
Participants 14802 patients aged 65 or over in 25
intervention and 25 control practices.
Interventions Patients in intervention practices were
randomly allocated to systematic screening (invitation for
electrocardiography) or opportunistic screening (pulse
taking and invitation for electrocardiography if the pulse
was irregular). Screening took place over 12 months in
each practice from October 2001 to February 2003. No
active screening took place in control practices.
Main outcomemeasureNewly identified atrial fibrillation.
Results The detection rate of new cases of atrial
fibrillation was 1.63% a year in the intervention practices
and 1.04% in control practices (difference 0.59%, 95%
confidence interval 0.20% to 0.98%). Systematic and
opportunistic screening detected similar numbers of new
cases (1.62% v 1.64%, difference 0.02%, −0.5% to
0.5%).
Conclusion Active screening for atrial fibrillation detects
additional cases over current practice. The preferred
methodof screening in patients aged 65or over in primary
care is opportunistic pulse taking with follow-up
electrocardiography.
Trial registration Current Controlled Trials
ISRCTN19633732.
INTRODUCTION
Atrial fibrillation is a major risk factor for throm-
boembolic disease, particularly stroke.1 Its prevalence
rises with age, from about 1% in the whole population
to about 5% in people aged over 65.2 It can be
diagnosed by means of a simple low cost test
(electrocardiography), which is acceptable to most
patients. The risk of serious sequelae, such as stroke,
can be dramatically reduced by treatment, with a
68% relative risk reduction for ischaemic stroke and
25% reduction in relative mortality associated with
warfarin therapy compared with placebo.3 Atrial
fibrillation therefore fulfils many of theWilson-Junger
criteria for a screening programme.4
Two potential population screening strategies
include opportunistic case finding and systematic
screening. In opportunistic case finding, a healthcare
professional would take a patient’s pulse during a
consultation. If the pulse was irregular electrocardio-
graphy would be performed as a confirmatory test as
an irregular pulse is a non-specific predictor of atrial
fibrillation.5 In systematic screening, the whole target
population would be invited for screening by electro-
cardiography.
One study in the United Kingdom compared sys-
tematic screening led by nurses with prompted oppor-
tunistic case finding for atrial fibrillation in primary
care (four practices, n=3001). The systematic screening
detected more cases than opportunistic case finding,
but atrial fibrillation had already been diagnosed in
many of the participants and the screening period
was only six months, making its generalisability
unclear.6 Two further studies based in single practices
investigated the role of practice nurses in the screening
process7 and whole population screening8: the first
study suggested that opportunistic screening with the
pulse taken by a nurse and 12 lead electrocardiography
was themost effective screening strategy, while the sec-
ond study investigated only population screening. It
therefore remains unclear which, if any, screening
strategy should be adopted.
As part of the screening for atrial fibrillation in the
elderly (SAFE) study, we tested whether screening was
more effective than routine care in detecting atrial
fibrillation in the community and, in a subsidiary
randomisation within the screening arm, compared
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opportunistic screening with total population
screening.
METHODS
Design and setting
This was amulticentred cluster randomised controlled
trial (figure) of computerised general practices in Eng-
land, with individual randomisation of patients in
intervention practices to two different screening strate-
gies.
Participants
We recruited 50 general practices from the Midlands
Research Practices Consortium (MidReC). All
patients aged 65 or over from these practices were eli-
gible for participation in the study, though patients
could be excluded if their own general practitioner
thought participation inadvisable.
Randomisation and sequence generation
Main trial
After stratification for practice size and deprivation
(based on Townsend score), we used MINITAB to
select randomly two equal size groups from those prac-
tices within a particular stratum. We used a simulated
value from a Bernoulli distribution, comprising two
values equally likely to occur, to determine which
group became the intervention arm (the other being
the control arm).
Subsidiary trial
After stratification for known atrial fibrillation (see
below) we randomly allocated patients from the 25
intervention practices to systematic or opportunistic
screening.
We obtained a computerised list of all patients aged
65 or over from each practice. From these we intended
to identify random samples of 400 patients from each
intervention practice, and 200 from each control prac-
tice. As not all practices had as many as 400 eligible
patients we selected 440 patients from practices with
more than 900 eligible patients, 420 patients fromprac-
ticeswith between 420 and900 eligible patients, and all
eligible patients from practices with fewer than 420 eli-
gible patients. Random selection of patients for each
practice was achieved with computer generated ran-
dom numbers (MINITAB) to access entries in lists of
patients. For control practices only onepractice did not
contribute 200 patients and no adjustment was made.
After initial sampling, we returned the lists of
patients to the practices and asked them to remove
the names of any patients who had died, moved, or
were terminally ill. These were replaced by a further
random selection of patients from a reserve list of 10%
drawn up for each practice. The cleaned lists fromeach
practice were classified into strata on the basis of
whether or not atrial fibrillation had been previously
diagnosed (see below). We used SPSS to allocate
patients randomly from this list to either systematic
or opportunistic screening to create two equal size
groups of patients within each stratum so that each
strategy (systematic or opportunistic screening) had
an equal chance of detecting known, unknown, and
suspected atrial fibrillation (n=4933). Which group
then became the systematic arm (the other being
opportunistic) was again decided by using a simulated
value from a Bernoulli distribution, comprising two
values equally likely to occur.
Before we flagged notes or invited patients for elec-
trocardiography, the general practitioners scrutinised
practice lists for a second time to remove any names of
patients who had died, moved, or were terminally ill,
and these patients were not replaced.
Blocking
Wedid not use explicit blocking in either themain trial
or the subsidiary trial but achieved balance at the selec-
tion stage by sampling equal numbers from stratified
lists of practices and patients.
Allocation concealment
There was no deliberate concealment of allocation to
the trial arms, but the trial management team did not
reveal the classification of atrial fibrillation to the par-
ticipants. The trial statistician determined allocation,
which was implemented by the trial coordinator
Practices enrolled (n=50)
Cluster randomisation
Intervention practices (n=25)
Total eligible population aged ≥65=23 187
(range 90-2726/practice)
Control practices (n=25):
Total eligible population aged ≥65=21 786
(range 149-2496/practice)
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Control arm:
Cluster size: 136-200,
average 197
Patients allocated to
control arm (n=4936)
Opportunistic arm:
4933 patients allocated to
opportunistic screening arm
Systematic arm:
4933 patients allocated to total
population systematic arm
Notes flagged (n=4738)
Pulses recorded (n=3278)
Electrocardiography
  performed (n=238)
Known cases of atrial
  fibrillation at baseline
  (n=340)
Case notes unavailable for
  analysis (n=18)
Invited for electro-
  cardiography (n=4433)
Electrocardiography
  performed (n=2357)
Known cases of atrial
  fibrillation at baseline
  (n=339)
Case notes unavailable for
  analysis (n=32)
Random sampled population 
cluster size (82-440)
Excluded by
practices (n=500)
Individual randomisation
Patients’ notes unavailable
for analysis (n=34)
New cases detected
(n=47, range 0-5,
average 1.88/cluster)
New cases detected
(n=75, range 0-8,
average 3.0/cluster)
New cases detected
(n=74, range 0-8,
average 2.96/cluster)
Excluded by
practices (n=195)
Distribution of practices and participants through stages of study
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Baseline data collection
Identification of atrial fibrillation already known to
practices
We carried out computer searches of practice registers
to identify cases of atrial fibrillation in the 15 000 study
patients using a previously published strategy.9 In
addition, we identified cohorts of patients receiving
prescriptions of digoxin, β blockers, class 1, 3, or 4
anti-arrhythmic drugs, aspirin, or warfarin. Clinical
records of patients thus identified as having atrial fibril-
lation or taking drugs that were associated with a diag-
nosis of atrial fibrillation in any of these computer
searches were reviewed for mention of a diagnosis of
atrial fibrillation. A diagnosis was accepted if there
were hospital letters referring to atrial fibrillation or
confirmatory electrocardiograms within the previous
five years.We reviewed an additional 5% randomsam-
ple of case notes of patients not identified on the com-
puter searches (750 in all) to estimate how many other
patients known to have atrial fibrillationwere not iden-
tified by the computer search strategy.
Intervention
Primary care physicians and other members of the pri-
mary healthcare team in the intervention practices
attended investigator days at which they were given
educational materials informing them of the impor-
tance of detecting atrial fibrillation and the available
treatment options. Members of primary healthcare
teams from control practices received no educational
input.
Practice nurses attended an electrocardiography
training day before they started screening clinics.
Training included how to perform electrocardiogra-
phy (with an electronicmachine to ensure standardised
high quality tracings) and basic interpretation of the
electrocardiogram (specifically how to identify atrial
fibrillation). Screening was undertaken in phases
because of the large number of practices, with the
first practice starting screening in October 2001 and
the last practice finishing screening in February 2003,
with each practice undertaking 12 months of screen-
ing.
All patients allocated to systematic screening
(including those with known atrial fibrillation) were
invited by post to attend a screening clinic. The notes
of patients in the opportunistic arm (including those
with known atrial fibrillation) were flagged with either
a manual paper flag or computer flag to encourage
pulse recording during routine consultation. Patients
with an irregular pulse were invited to attend a screen-
ing clinic. Once this process had been undertaken, the
flag was removed from the notes and returned to the
research team.
Practice nurses at the screening clinic obtained con-
sent from patients. Thus only those patients who
responded to the invitation in the systematic arm
(n=2357) and those with an irregular pulse in the
opportunistic arm (n=238) provided informedconsent.
No data were available for those who failed to respond
and therefore did not give consent. All data relating to
patients were anonymised before they left the general
practice, and all research staff held honorary contracts
with the participating centres.
Practice nurses ran the screening clinics and col-
lected baseline information and medical history
(including any previous diagnosis of atrial fibrillation),
took the radial pulse, and carried out 12 lead electro-
cardiography (Biolog, Numed, Sheffield, UK). Two
consultant cardiologists (GL, MD), who were blinded
to allocation, assessed whether the electrocardiogram
showed atrial fibrillation or not and identified any
other relevant abnormalities. A third blinded cardio-
logist arbitrated on any disagreements over diagnosis.
Patients with normal findings on electrocardiography
were informed within two weeks and patients with any
abnormality were asked to make an appointment with
their general practitioner.
Main outcome measures
Our primary outcomemeasurewas the number of new
cases of atrial fibrillation detected during the 12month
study period (newly identified atrial fibrillation). To
detect new cases in control practices we carried out
computer searches of patients’ notes at baseline (see
above) and after 12months of screening.We reviewed
case notes of patients identified in these computer
searches for evidence of atrial fibrillation (using the
same criteria as above).
We assessed acceptability to patients using an
adapted version of the screening specific tool used in
the colorectal screening programme.10 All patients
screenedwere asked to complete an acceptability ques-
tionnaire immediately after screening.
Sample size
We assumed that the baseline prevalence of atrial
fibrillation known to the practice would be 3% (half
the expected prevalence of 6%11) and that this preva-
lence would remain constant within the control
Table 1 | Practice population by age and sex according to screening for atrial fibrillation
All Control
Intervention
Total Opportunistic Systematic
No of patients 14 802 4936 9866 4933 4933
Men (%) 6302 (42.6) 2079 (42.1) 4223 (42.8) 2104 (42.7) 2119 (43.0)
Mean age (SD) 75.3 (7.2) 75.5 (7.2) 75.2 (7.2) 75.1 (7.1) 75.2 (7.3)
Median age 74.1 74.5 73.9 74.0 73.8
Age <75 (%) 8059 (54.4) 2597 (52.6) 5465 (55.4) 2755 (55.8) 2710 (54.9)
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practices. To have 90% power at a significance level of
5% todetect a 1%difference in the detection rate of new
cases of atrial fibrillation between the different arms of
the study we required 5000 patients in 25 practices
(cluster size 200) in each group. This assumed an intra-
cluster correlation coefficient of 0.015 (derived from
prevalence data from a previous study).11
Statistical methods
We analysed data on an intention to treat basis. We
subtracted any previously known cases of atrial fibril-
lation from the totals obtained at the end of the study to
prevent double counting in the newly identified atrial
fibrillation figures. Proportions and rates were used as
the measures of prevalence and newly identified atrial
fibrillation. We used χ2 test to compare overall
12 month prevalence and incidence rates between
arms.
Incidence analysis
Weused non-linearmixedmodels with binomial error
to examine variation from arm to arm in the rates of
newly identified atrial fibrillationwithin the total popu-
lation minus the population with known atrial fibrilla-
tion (n=13 734), allowing for age (modelled as above or
below the median age (73.66) of those patients within
this reduced population) and sex and including both
main effects and interaction terms. Practice was
defined as a random effect to account for extra bino-
mial variability at the practice level. Any difference in
baseline prevalence at practice level was accounted for
with the inclusion of the log odds of baseline atrial
fibrillation. These analyses were conducted using
Proc Nlmixed in SAS (version 8.2) (SAS, Carey, NC).
The analysis was repeated without the inclusion of the
covariate describing baseline prevalence.
We used logistic regression to compare rates of
newly identified atrial fibrillation per practice in the
control and intervention arms and also in a matched
pairs analysis of 12 month incidence between the
opportunistic and systematic arms.
RESULTS
Participant flow
Table 1 gives details of age and sex of the study parti-
cipants by screening arm. We reviewed case notes of
5216 (35%) of the total study population at baseline
because they had been picked up on computer search
as having atrial fibrillation or relevant drug code.
Baseline prevalence of atrial fibrillation
We confirmed atrial fibrillation in 1068 patients
(20.5% of search positive population, and 7.3% of
total population) by reviewing clinical records. Case
notes were unavailable for 21 patients. In the addi-
tional random 750 sets of case notes that we reviewed
as a validation of the computer searches, we found no
extra cases of atrial fibrillation. The baseline preva-
lence was 7.9% (95% confidence interval 7.2% to
8.7%) in the control arm and 6.9% (6.2 to 7.6%) in
both the opportunistic and systematic arms. The intra-
class correlation was 0.0027 across all practices.
Newly identified atrial fibrillation over 12 months
Table 2 shows the number of new cases of atrial fibril-
lation found through searching notes at 12 months
after the baseline search. We calculated rates of newly
identified atrial fibrillation after removing those
patients in whom atrial fibrillation was diagnosed at
baseline and patients whose notes could not be
found. Newly identified atrial fibrillation therefore
refers to the number of new cases diagnosed within the
12 month study period. Data were missing for patients
whose notes were no longer available because of death
or no longer being at the practice. The overall mean
12 month prevalence was 8.9% (7.9% to 9.7%) in the
control arm, 8.4% (7.6% to 9.4%) in the opportunistic
arm, and 8.4% (7.6% to 9.3%) in the systematic arm.
The detection rate of new cases of atrial fibrillation
was 1.63% a year in the intervention practices and
1.04% in control practices (difference 0.59%, 0.20%
to 0.98). Systematic and opportunistic screening
detected similar new numbers of cases (1.62% and
1.64%; difference 0.02%, −0.5% to 0.5%) (table 2).
After we accounted for possible practice to practice
variation using amixedmodelwith binomial error var-
iation,we found a significant difference in the detection
of new cases of atrial fibrillation between the control
arm and the opportunistic and systematic arms
(P=0.01 and P=0.02, respectively) but not between
the opportunistic and systematic arms (P=0.95).
Within each of the three arms there was no significant
practice to practice variation (P=0.88, P=0.62, and
P=0.96, respectively). After we accounted for baseline
prevalence, screening practices identified substantially
more cases of atrial fibrillation than the control prac-
tices (odds ratio 1.61, 1.14 to 2.29, P=0.0085), and we
obtained similar results when we removed baseline
prevalence from the model (1.58, 1.12 to 2.22,
Table 2 | New cases of atrial fibrillation (AF) by trial arm identified in case notes 12months after baseline
Group Patients Baseline AF Missing notes Denominator
Newly identified
cases New case detection %
Control 4936 389 34 4513 47 1.04
Intervention:
Total 9866 679 50 9137 149 1.63
Opportunistic* 4933 340 18 4575 75 1.64
Systematic* 4933 339 32 4562 74 1.62
*Subsets of total intervention population.
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P=0.0103). Amatched pairs logistic regression analysis
between patients from the same practices allocated to
either the opportunistic or systematic arms showed no
significant difference in detection of new cases of atrial
fibrillation at 12 months (P=0.67) or between practices
(P=0.60).
Opportunistic v systematic screening
We identified 75 new cases of atrial fibrillation in the
opportunistic screening group and 74 new cases in the
systematic screening group. Differences in screening
method had no effect on the rate of detection between
the groups (odds ratio 0.99, 0.72 to 1.37, P=0.95).
In total 3278 (69%) patients were opportunistically
screened for atrial fibrillation during the 12 months of
the study. After they had had their pulse taken, 122/
360 (34%) patients with an irregular pulse declined
electrocardiography. Of the remaining patients, atrial
fibrillation was diagnosed in 84/238 (35%) on electro-
cardiography (2.6% of patients who had their pulse
taken). Of patients who had an irregular pulse but no
electrocardiography, atrial fibrillation had already
been confirmed in 56/122 (46%). Of the 75 new cases
of atrial fibrillation in the opportunistic arm, 24 had a
regular pulse recorded but subsequently had atrial
fibrillation diagnosed outside the screening pro-
gramme. The irregular pulse could have been missed
in these 24 patients; or they could have developed
atrial fibrillation subsequent after they had their pulse
taken; or theymay have had paroxysmal atrial fibrilla-
tion.We cannot distinguish between these three possi-
bilities.
Of the 4433 patients invited for systematic screen-
ing, 2357 (53%) underwent electrocardiography, 904
(20%) declined screening, and 992 (22%) did not
respond. Some 135 (6%) were found to have atrial
fibrillation, which was a new diagnosis in 52 (39%)
(the 22 additional cases were detected outside the
screening programme).
Prevalence of paroxysmal atrial fibrillation
Of the 339 intervention patients confirmed to have
atrial fibrillation at baseline and randomised to
systematic screening, 205 underwent screening elec-
trocardiography during the study, which confirmed
atrial fibrillation in 136 (66%). The electrocardiogram
showed sinus rhythm in 69 (34%). Thus, about a third
of prevalent atrial fibrillation at baseline was either self
limiting or paroxysmal.
All patients undergoing electrocardiography
(n=2595) were given a questionnaire after screening,
of which 1940 (75%) were returned completed. Most
(95%) respondents thought that screening was impor-
tant and that sufficient information was available
before screening.
DISCUSSION
In this multicentred study we have identified the most
effective manner of screening for atrial fibrillation in
patients aged 65 or over. Opportunistic screening
with opportunistic pulse taking, prompted by flagged
case notes, during routine clinic attendances and then
performing 12 lead electrocardiography on those with
an irregular pulse was as effective as systematic popu-
lation screening, with both being more effective than
“routine practice,” which comprised non-systematic
case finding. This finding suggests that routine electro-
cardiography within this population is unnecessary for
the detection of atrial fibrillation as long as healthcare
professionals are conscientious about feeling the pulse.
The utility of opportunistic screening was undoubt-
edly due in part to the extensive coverage attained over
the 12 month study period (69%) in contrast to a lower
coverage rate (29%) over a six month period in the
Southampton study.6 Within SAFE opportunistic
pulse taking was encouraged by the flagging of clinical
notes. This was predominantly manual, though with
the increase in the use of wholly computerised records,
and improvements in practice administration driven
by incentives, such as the quality and outcomes frame-
work in the UK, the potential for opportunistic screen-
ing will probably increase. The validity of our findings
may be transferable to any system of managed care
where high rates of coverage can be achieved.
Therewas no significant difference in themean com-
munity prevalence of atrial fibrillation at 12 months
Table 3 | Prevalence and detection rate of new cases by age at start of study and sex. Figures are numbers (percentages)
Group
Men Women
Total65-74 75-84 ≥85 65-74 75-84 ≥85
Baseline prevalence
Control 74/1216 (6.1) 84/703 (11.9) 25/156 (16.0) 44/1378 (3.2) 106/1050(10.1) 56/420 (13.3) 389/4923 (7.9)
Opportunistic 70/1304 (5.4) 63/650 (9.7) 24/148 (16.2) 48/1448 (3.3) 91/1005 (9.1) 44/375 (11.7) 340/4930 (6.9)
Systematic 69/1318 (5.2) 67/647 (10.4) 15/154 (9.7) 68/1391 (4.9) 70/1022 (6.8) 50/396 (12.6) 339/4928 (6.9)
12 month prevalence
Control 81/1213 (6.7) 91/699 (13.0) 27/151 (17.9) 55/1377 (4.0) 122/1044(11.7) 60/418 (14.4) 436/4902 (8.9)
Opportunistic 90/1303 (6.9) 77/647 (11.9) 28/148 (18.9) 59/1443 (4.1) 109/1001(10.9) 52/373 (13.9) 415/4915 (8.4)
Systematic 90/1312 (6.9) 82/643 (12.8) 23/154 (14.9) 77/1387 (5.6) 88/1012 (8.7) 53/398 (13.5) 413/4906 (8.4)
12 month new case detection
Control 7/1139 (0.6) 7/615 (1.1) 2/126 (1.6) 11/1333 (0.8) 16/938 (1.7) 4/362 (1.1) 47/4513 (1.0)
Opportunistic 20/1233 (1.6) 14/584 (2.4) 4/124 (3.2) 11/1395 (0.8) 18/910 (2.0) 8/329 (2.4) 75/4575 (1.6)
Systematic 21/1243 (1.7) 15/576 (2.6) 8/139 (5.8) 9/1319 (0.7) 18/942 (1.9) 3/343 (0.9) 74/4562 (1.6)
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between the three arms of the study. The baseline pre-
valence was 6.9%-7.9% in those aged 65 or over. The
SAFE prevalence rates of atrial fibrillation represent
more robust estimates than the previously reported
prevalence in this population of 4.5% from systematic
screening6 and 5.4% from total population screening.8
Routinely reported data for those aged 85 or over has
suggested a prevalence of atrial fibrillation of around
10%,2 significantly lower than we found in our study.
These earlier studieswere small and in less investigated
populations and probably systematically under-
reported atrial fibrillation, whereas the SAFE popula-
tion was, by design, much larger and more representa-
tive than earlier studies with more robust methods of
screening. General practitioners removed more
patients from the opportunistic screening arm than
from the systematic screening arm, although the same
criteriawere used for removal. This discrepancy is rela-
tively small and does not affect our main outcome.
Little information is available on the rate of newly
identified atrial fibrillation. One small Scottish study
in younger people (45-64) reported a four year
incidence of 0.54 per 1000 patient years.12 In this
study there were also significant differences between
the populations, with the detection rate being
significantly higher in screened populations than in
routine practice.
The prevalence and incidence rates for atrial fibrilla-
tion in SAFE are therefore likely to represent reliable
estimates for theUK (table 3). The screeningprocesses,
whether systematic or opportunistic, did not raise anxi-
ety and were acceptable to patients. As the detection
rates were essentially identical for the two methods,
however, the more labour intensive, costly, and intru-
sive approach with systematic screening cannot be jus-
tified. Furthermore, systematic screening was much
less acceptable to patients overall, with over 20% posi-
tively declining the offer and over 26% not responding
to the offer.
Limitations of study
Our study was complicated by the fact that the control
population had a higher prevalence of atrial fibrillation
at baseline, which we assumed to be a random finding.
This had to be corrected for in the analysis. Further
study limitations included the inability to detect all
cases of paroxysmal atrial fibrillation (although this
was presumed in patients whose case notes indicated
atrial fibrillation but whose electrocardiograms were
negative) and the poor uptake of systematic screening.
These data do not directly tell us how often screening
should take place, though this will be estimated in
future economic modelling of the clinical yields on
the basis of the observed new detection rates. We will
also model the effect of antithrombotic treatment on
the incident cases. This will affect the cost effectiveness
of any screening programme, given that the earlier
atrial fibrillation is detected the sooner antithrombotic
treatment can start. It is not clear how uptake in
patients would be affected if this became a routine pro-
cedure. Patientsmay have been reluctant to participate
in a research project as opposed to undertaking a rou-
tine screen. Uptake of cervical screening, for example,
improved dramatically over the past decade as it
became routine.13
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Atrial fibrillation is a major modifiable risk factor for stroke
Atrial fibrillation is underdiagnosed and undertreated in the community
WHAT THIS STUDY ADDS
Screening in general practice will identify new cases of atrial fibrillation
Opportunistic screening with pulse taking followed by electrocardiography is as effective as
systematic screening of patients aged 65 or over
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